scholarly journals B-PO05-024 BIOLOGICAL LIFE-STAGE, MENARCHE ONSET, AND THE BURDEN OF CARDIAC EVENTS IN WOMEN WITH CONGENITAL LONG QT SYNDROME

Heart Rhythm ◽  
2021 ◽  
Vol 18 (8) ◽  
pp. S381
Author(s):  
Arwa Younis ◽  
Wojciech Zareba ◽  
Adnan Kharsa ◽  
Christopher Bodurian Scott McNitt ◽  
Mehmet K. Aktas ◽  
...  
2010 ◽  
Vol 55 (10) ◽  
pp. A130.E1215
Author(s):  
James A. Kim ◽  
Arthur J. Moss ◽  
Coeli M. Lopes ◽  
Scott McNitt ◽  
Jennifer L. Robinson ◽  
...  

2012 ◽  
Vol 76 (9) ◽  
pp. 2112-2118 ◽  
Author(s):  
Masateru Takigawa ◽  
Mihoko Kawamura ◽  
Takashi Noda ◽  
Yuko Yamada ◽  
Koji Miyamoto ◽  
...  

2008 ◽  
Vol 72 (5) ◽  
pp. 694-699 ◽  
Author(s):  
Iori Nagaoka ◽  
Wataru Shimizu ◽  
Hideki Itoh ◽  
Satoshi Yamamoto ◽  
Tomoko Sakaguchi ◽  
...  

Circulation ◽  
2011 ◽  
Vol 123 (24) ◽  
pp. 2784-2791 ◽  
Author(s):  
Jonathan Buber ◽  
Jehu Mathew ◽  
Arthur J. Moss ◽  
W. Jackson Hall ◽  
Alon Barsheshet ◽  
...  

2021 ◽  
Vol 15 ◽  
Author(s):  
Caroline Taylor ◽  
Bruce S Stambler

Congenital long QT syndrome (LQTS) is a primary genetic and electrical disorder that increases risk for torsades de pointes, syncope, and sudden death. Post-pubertal women with LQTS require specialized multidisciplinary management before, during, and after pregnancy involving cardiology and obstetrics to reduce risk for cardiac events in themselves and their fetuses and babies. The risk of potentially life-threatening events is lower during pregnancy but increases significantly during the 9-month postpartum period. Treatment of women with LQTS with a preferred β-blocker at optimal doses along with close monitoring are indicated throughout pregnancy and during the high-risk postpartum period.


Heart Rhythm ◽  
2011 ◽  
Vol 8 (8) ◽  
pp. 1207-1213 ◽  
Author(s):  
Alon Barsheshet ◽  
Derick R. Peterson ◽  
Arthur J. Moss ◽  
Peter J. Schwartz ◽  
Elizabeth S. Kaufman ◽  
...  

2020 ◽  
pp. 021849232097149
Author(s):  
Savvas Lampridis ◽  
Achilleas Antonopoulos ◽  
Christos Kakos ◽  
Sofoklis Mitsos ◽  
Davide Patrini ◽  
...  

Background Congenital long-QT syndrome represents the most common cardiac channelopathy and manifests as potentially lethal ventricular arrhythmias. Prevention strategies include beta-blockade pharmacotherapy, implantable cardioverter-defibrillators, and left cardiac sympathetic denervation, which can increase the threshold for ventricular fibrillation. Herein, we report our experience with video-assisted thoracoscopic left cardiac sympathetic denervation. Methods We performed a retrospective review of the electronic medical records of all patients with congenital long-QT syndrome who underwent video-assisted thoracoscopic left cardiac sympathetic denervation at our institution. Results From September 2009 to May 2016, 6 patients with a mean age of 30.5 years (range 20–47 years) underwent video-assisted thoracoscopic left cardiac sympathetic denervation for medically refractory long-QT syndrome. All patients had an uneventful recovery and were discharged 1–3 days after the operation. At a median follow-up of 14 months (range 12–60 months), 4 patients had no cardiac events while 2 experienced 1 episode of arrhythmic syncope and 1 episode of appropriate implantable cardioverter-defibrillator shock. Following surgery, the mean annual cardiac events in the study cohort decreased from 2.13 to 0.33 ( p = 0.004) and the mean corrected QT interval reduced from 560 ms to 491 ms ( p = 0.006). Conclusions Video-assisted thoracoscopic left cardiac sympathetic denervation is a safe and effective therapy in patients with congenital long-QT syndrome who continue to suffer from recurrent life-threatening arrhythmias or frequent implantable cardioverter-defibrillator discharges despite maximum tolerated doses of beta blockers.


Heart Rhythm ◽  
2004 ◽  
Vol 1 (1) ◽  
pp. 60-64 ◽  
Author(s):  
Anant Khositseth ◽  
David J Tester ◽  
Melissa L Will ◽  
Carla M Bell ◽  
Michael J Ackerman

2009 ◽  
Vol 9 (1) ◽  
pp. 111-112
Author(s):  
Aris Lacis ◽  
Inga Lace ◽  
Elina Teivane ◽  
Vita Knauere ◽  
Inguna Lubaua ◽  
...  

Congenital Long QT Syndrome in an InfantLong QT syndrome (LQTS) is a disorder of myocardial repolarization characterized by prolonged QT interval on ECG with prevalence close to 1/3000-1/5000. LQTS is characterized by the occurrence of syncopal episodes due to torsades de pointes ventricular tachycardia (VT) and by a high risk for sudden cardiac death among untreated patients (1, 2, 3). In 12% of patients with LQTS, sudden death is the first manifestation of the disease and only in 4% this happens in the first year of life (2). There is consensus that all symptomatic children with LQTS should be treated with β-blockers which are effective in preventing cardiac events and reducing mortality in 70%, but do not protect patients from sudden death completely (1,2,3,4). The prognosis is poor in untreated patients with annual mortality 20% and 10 year mortality up to 50% (1, 2). Here we present a case of relatively rare congenital heart rhythm disorders in an infant which required immediate treatment.


Sign in / Sign up

Export Citation Format

Share Document